{"DataElement":{"publicId":"6641158","version":"1","preferredName":"Gene Function Rearrangement Result Text","preferredDefinition":"A free text that describes the DNA sequence and gene rearrangement as well as class switching of immunoglobulins.","longName":"GEN_FUN_REAGMNT_RES_TX","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"6641149","version":"1","preferredName":"Gene Function Gene Rearrangement Investigation Finding","preferredDefinition":"A term that expresses the function of a gene product._Any DNA sequence rearrangement that results in the creation of a novel protein-coding capacity. Within certain genes, gene rearrangement is a normal part of development, facilitating the affinity maturation of B and T lymphocytes as well as class switching of immunoglobulins._The result of an examination or inquiry.","longName":"6641146v1.0:6641147v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"6641146","version":"1","preferredName":"Gene Function","preferredDefinition":"A term that expresses the function of a gene product.","longName":"C48933","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Function","conceptCode":"C48933","definition":"A term that expresses the function of a gene product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"81B36A5D-48FC-6FFD-E053-F662850AC865","latestVersionIndicator":"Yes","beginDate":"2019-02-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-02-12","modifiedBy":"ONEDATA","dateModified":"2019-02-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6641147","version":"1","preferredName":"Gene Rearrangement Investigation Finding","preferredDefinition":"Any DNA sequence rearrangement that results in the creation of a novel protein-coding capacity. Within certain genes, gene rearrangement is a normal part of development, facilitating the affinity maturation of B and T lymphocytes as well as class switching of immunoglobulins.:The result of an examination or inquiry.","longName":"C16611:C61036","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Rearrangement Process","conceptCode":"C16611","definition":"Any DNA sequence rearrangement that results in the creation of a novel protein-coding capacity. Within certain genes, gene rearrangement is a normal part of development, facilitating the affinity maturation of B and T lymphocytes as well as class switching of immunoglobulins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Investigation Finding","conceptCode":"C61036","definition":"The result of an examination or inquiry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81B36A5D-490D-6FFD-E053-F662850AC865","latestVersionIndicator":"Yes","beginDate":"2019-02-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-02-12","modifiedBy":"ONEDATA","dateModified":"2019-02-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"81B36A5D-491E-6FFD-E053-F662850AC865","latestVersionIndicator":"Yes","beginDate":"2019-02-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-02-12","modifiedBy":"SOKKERL","dateModified":"2020-02-18","changeDescription":"2/12/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5076316","version":"1","preferredName":"Descriptive 2000 Text","preferredDefinition":"The text that provides a description of a topic.","longName":"5076316v1.0","context":"ONC SDC Project","contextVersion":"1","type":"Non-enumerated","dataType":"ALPHANUMERIC","minLength":"1","maxLength":"2000","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"FDA: FDA GUDID (Global Unique Device Identification Database)","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2651F0E1-431F-DD28-E050-BB89AD4365E5","latestVersionIndicator":"Yes","beginDate":"2015-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-12-07","modifiedBy":"REEVESD","dateModified":"2015-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Likely Functional Rearrangeme","type":"Preferred Question Text","description":"Likely Functional Rearrangements","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"81B391D1-74DF-0DB1-E053-F662850AF311","latestVersionIndicator":"Yes","beginDate":"2019-02-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-02-12","modifiedBy":"SOKKERL","dateModified":"2020-02-18","changeDescription":"2/12/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}